Uk Astrazeneca Vaccine
- All
- News
- Videos
-
Covishield Side Effects: Doctors' Group Urges Centre To Review All Covid Vaccines
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.
-
What Is TTS, A Rare Condition Caused By AstraZeneca's Covishield Vaccine
AstraZeneca, a British pharmaceutical giant, has admitted that its Covid-19 vaccine can result ina rare side effectknown as Thrombosis with Thrombocytopenia Syndrome (TTS).T
-
AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects
British pharma giant AstraZeneca has admitted that its Covid vaccine can cause rare side effects, The Telegraph (UK) has reported.
-
Exclusive: Indian Students In UK Can Get Booster Shots At Walk-In Vaccination Centres
Indian students in the United Kingdom who have received two doses of AstraZeneca's Covishield vaccine will be able to get a booster shot, as per the new protocol announced by British Prime Minister Boris Johnson.
-
Mixing Covid Vaccines Is Effective In Study on Pfizer, AstraZeneca
Mixing other vaccines with those from AstraZeneca Plc or Pfizer Inc. offers at least as effective protection against Covid-19 as giving two doses of the same shots, a UK study found.
-
COVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: Report
A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday.
-
Blood Clot Risk Much Higher From Covid Than With Vaccines: UK Study
Covid-19 patients face a much higher risk of developing blood clots than those vaccinated with AstraZeneca Plc or Pfizer Inc.'s shots, according to a large U.K. study.
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
-
Covishield Shot Should Be Accepted In Travel Schemes: UK's Boris Johnson
British Prime Minister Boris Johnson on Friday said he saw no reason why people who received Indian-made AstraZeneca COVID-19 vaccines should be left out of vaccine passport schemes after the European Union did not initially recognise it.
-
Two Doses Mostly Prevent Hospitalisation With Delta Variant: UK Body
Two doses of COVID-19 vaccines are "highly effective" in preventing hospital admission with the Delta variant, Public Health England said on Monday.
-
Covishield Side Effects: Doctors' Group Urges Centre To Review All Covid Vaccines
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.
-
What Is TTS, A Rare Condition Caused By AstraZeneca's Covishield Vaccine
AstraZeneca, a British pharmaceutical giant, has admitted that its Covid-19 vaccine can result ina rare side effectknown as Thrombosis with Thrombocytopenia Syndrome (TTS).T
-
AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects
British pharma giant AstraZeneca has admitted that its Covid vaccine can cause rare side effects, The Telegraph (UK) has reported.
-
Exclusive: Indian Students In UK Can Get Booster Shots At Walk-In Vaccination Centres
Indian students in the United Kingdom who have received two doses of AstraZeneca's Covishield vaccine will be able to get a booster shot, as per the new protocol announced by British Prime Minister Boris Johnson.
-
Mixing Covid Vaccines Is Effective In Study on Pfizer, AstraZeneca
Mixing other vaccines with those from AstraZeneca Plc or Pfizer Inc. offers at least as effective protection against Covid-19 as giving two doses of the same shots, a UK study found.
-
COVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: Report
A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday.
-
Blood Clot Risk Much Higher From Covid Than With Vaccines: UK Study
Covid-19 patients face a much higher risk of developing blood clots than those vaccinated with AstraZeneca Plc or Pfizer Inc.'s shots, according to a large U.K. study.
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
-
Covishield Shot Should Be Accepted In Travel Schemes: UK's Boris Johnson
British Prime Minister Boris Johnson on Friday said he saw no reason why people who received Indian-made AstraZeneca COVID-19 vaccines should be left out of vaccine passport schemes after the European Union did not initially recognise it.
-
Two Doses Mostly Prevent Hospitalisation With Delta Variant: UK Body
Two doses of COVID-19 vaccines are "highly effective" in preventing hospital admission with the Delta variant, Public Health England said on Monday.
